首页> 外国专利> TREATMENT AND PREVENTION OF BENIGN PIGMENTED MOLES (NAEVI) USING ARTEMISININE AND THE DERIVATIVES THEREOF

TREATMENT AND PREVENTION OF BENIGN PIGMENTED MOLES (NAEVI) USING ARTEMISININE AND THE DERIVATIVES THEREOF

机译:使用青蒿素治疗和预防良性色素痣(NAEVI)及其衍生物

摘要

Benign pigmented moles of the skin or mycosis pedis or nail fungus can betreated withlocally applicable, in particular topically formulated active ingredients offormula (I), inwhich formula (I) X represents CO, CHOZ or CHNRZ, Z being selected fromhydrogen;straight-chain and branched (C1-C6) alkyl; straight-chain or branched (C2-C6)alkenyl;straight-chain or branched (C2-C6) alkynyl; (C3-C8) cycloalkyl; (C6-C24) aryl;(C7-C24)aralkyl; m- and p-CH2(C6H4)COOM; COR3; CSR3; C(NR6)R3; SOR4; SO2OM;SO2NR7R8; SO2O-artemisinyl; SO2NH-artemisinyl; POR4R5 and PSR4R5; wherein R3isstraight-chain or branched (C1-C6) alkyl; straight-chain or branched (C1-C6)alkoxy;straight-chain or branched (C2-C6) alkenyl; straight-chain or branched (C2-C6)alkynyl;(C3-C8) cycloalkyl; (C6-C24) alkyl; (C1-C10) aryloxy; (C7-C24) aralkyl; -(CH2)n-COOM,with n as an integer of from 1 through 6; or 10.alpha.-dihydroartemisinyl; R4and R5 areselected independently of one another from straight-chain or branched (C1-C6)alkyl;straight-chain or branched (C2-C6) alkenyl; straight-chain or branched (C2-C6)alkynyl;(C3-C8)cycloalkyl; (C6-C24) aryl; (C7-C24) aralkyl; OM; straight-chain orbranched (C1-C6) alkoxy; (C6-C10) aryloxy and NR7R8; R6 is selected from straight-chain orbranched(C1-C6) alkyl; straight-chain or branched (C2-C6) alkenyl; straight-chain orbranched (C2-C6) alkynyl; (C3-C8) cycloalkyl; (C6-C24) aryl and (C7-C24) aralkyl; M ishydrogen or apharmaceutically acceptable cation; and R7 and R8 independently of one anotherarehydrogen or straight-chain or branched (C1-C6) alkyl, or R7 and R8 togetherform a (C4-C6) alkylene bridge; and R is selected from hydrogen and the groups listed forR6 . Thesecompounds are also effective in the prevention of acquired nevus cell nevi.
机译:皮肤或足癣真菌病或指甲真菌的色素沉着痣可以处理过当地适用的,特别是局部配制的活性成分式(I),在式(I)中的X表示CO,CHOZ或CHNRZ,Z选自氢;直链和支链(C1-C6)烷基;直链或支链(C2-C6)烯基直链或支链(C2-C6)炔基; (C3-C8)环烷基; (C6-C24)芳基;(C7-C24)芳烷基;间-和对-CH2(C6H4)COOM; COR3; CSR3; C(NR6)R3; SOR4; SO2OM;SO2NR7R8; SO 2 O-青蒿素; SO 2 NH-青蒿素; POR4R5和PSR4R5;其中R3是直链或支链(C1-C6)烷基;直链或支链(C1-C6)烷氧基直链或支链(C2-C6)烯基;直链或支链(C2-C6)炔基(C3-C8)环烷基; (C6-C24)烷基; (C1-C10)芳氧基; (C7-C24)芳烷基; --(CH2)n-COOM,n为1到6的整数;或10.α-二氢青蒿素; R4和R5是彼此独立选自直链或支链(C1-C6)烷基;直链或支链(C2-C6)烯基;直链或支链(C2-C6)炔基(C3-C8)环烷基; (C6-C24)芳基; (C7-C24)芳烷基; OM;直链或分支的(C1-C6)烷氧基; (C6-C10)芳氧基和NR7R8; R6选自直链或分枝的(C1-C6)烷基;直链或支链(C2-C6)烯基;直链或分支的(C2-C6)炔基; (C3-C8)环烷基; (C6-C24)芳基和(C7-C24)芳烷基; M是氢或药学上可接受的阳离子;和R7和R8彼此独立是氢或直链或支链(C1-C6)烷基,或R7和R8一起形成一个(C4-C6)亚烷基桥;和R选自氢和列出的基团R6。这些该化合物还有效预防获得性痣细胞痣。

著录项

  • 公开/公告号CA2626704C

    专利类型

  • 公开/公告日2015-12-15

    原文格式PDF

  • 申请/专利权人 EPIPHARM AG;

    申请/专利号CA20062626704

  • 发明设计人 SIFT CARTER ROSEMARIE;

    申请日2006-10-19

  • 分类号A61K31/357;A61K9/70;A61K31/366;A61L15/44;A61P17;C07D493/18;

  • 国家 CA

  • 入库时间 2022-08-21 14:21:59

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号